Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
Am J Kidney Dis
; 81(3): 294-306.e1, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36058429
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lupus Nephritis
/
Lupus Erythematosus, Systemic
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Am J Kidney Dis
Year:
2023
Type:
Article